Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the Hot-PE Trial (vol 116, pg 191, 2016)

Stefano Barco, Mareike Lankeit, Harald Binder, Sebastian Schellong, Michael Christ, Jan Beyer-Westendorf, Daniel Duerschmied, Rupert Bauersachs, Klaus Empen, Matthias Held, Martin Schwaiblmair, Cândida Fonseca, David Jimenez, Cecilia Becattini, Kurt Quitzau, Christine Espinola-Klein, Philipp Wild, Stavros Konstantinides

Research output: Contribution to journalBook/Film/Article reviewpeer-review

Original languageEnglish
Pages (from-to)775
Number of pages1
JournalTHROMBOSIS AND HAEMOSTASIS
Volume116
Issue number4
DOIs
Publication statusPublished - Oct 2016

Cite this